Cancer Research Targets Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehtesham, M.
Right arrow Articles by Yu, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehtesham, M.
Right arrow Articles by Yu, J. S.
[Cancer Research 62, 5657-5663, October 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

The Use of Interleukin 12-secreting Neural Stem Cells for the Treatment of Intracranial Glioma1

Moneeb Ehtesham, Peter Kabos, Andrea Kabosova, Toomas Neuman, Keith L. Black and John S. Yu2

Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048

Neural stem cells (NSCs) are capable of tracking migrating glioma cells. To exploit this tropism to generate an antitumor T-cell response, particularly against disseminating tumor pockets, we inoculated intracranial glioma-bearing mice with interleukin 12 (IL-12) producing NSCs. Intratumoral therapy with IL-12-secreting NSCs prolonged survival compared to treatment with nonsecretory NSCs or saline. NSCs demonstrated strong tropism for disseminating glioma, and IL-12-secreting NSC therapy was associated with enhanced T-cell infiltration in tumor microsatellites and long-term antitumor immunity. These results indicate that the use of tumor tracking NSCs represents a potent new therapeutic modality for glioma.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. M. Kim, J. Y. Lim, S. I. Park, C. H. Jeong, J. H. Oh, M. Jeong, W. Oh, S.-H. Park, Y.-C. Sung, and S.-S. Jeun
Gene Therapy Using TRAIL-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells against Intracranial Glioma
Cancer Res., December 1, 2008; 68(23): 9614 - 9623.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
A. M. Sonabend, I. V. Ulasov, M. A. Tyler, A. A. Rivera, J. M. Mathis, and M. S. Lesniak
Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
Stem Cells, March 1, 2008; 26(3): 831 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Pisati, M. Belicchi, F. Acerbi, C. Marchesi, C. Giussani, M. Gavina, S. Javerzat, M. Hagedorn, G. Carrabba, V. Lucini, et al.
Effect of Human Skin-Derived Stem Cells on Vessel Architecture, Tumor Growth, and Tumor Invasion in Brain Tumor Animal Models
Cancer Res., April 1, 2007; 67(7): 3054 - 3063.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-K. Kim, S. U. Kim, I. H. Park, J. H. Bang, K. S. Aboody, K.-C. Wang, B.-K. Cho, M. Kim, L. G. Menon, P. M. Black, et al.
Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Clin. Cancer Res., September 15, 2006; 12(18): 5550 - 5556.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
K. S. Aboody, J. Najbauer, N. O. Schmidt, W. Yang, J. K. Wu, Y. Zhuge, W. Przylecki, R. Carroll, P. M. Black, and G. Perides
Targeting of melanoma brain metastases using engineered neural stem/progenitor cells
Neuro-oncol, April 1, 2006; 8(2): 119 - 126.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Yuan, J. Hu, M. L. Belladonna, K. L. Black, and J. S. Yu
Interleukin-23-Expressing Bone Marrow-Derived Neural Stem-Like Cells Exhibit Antitumor Activity against Intracranial Glioma.
Cancer Res., March 1, 2006; 66(5): 2630 - 2638.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
J. S. Meyer, M. L. Katz, J. A. Maruniak, and M. D. Kirk
Embryonic Stem Cell-Derived Neural Progenitors Incorporate into Degenerating Retina and Enhance Survival of Host Photoreceptors
Stem Cells, February 1, 2006; 24(2): 274 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
O. Heese, A. Disko, D. Zirkel, M. Westphal, and K. Lamszus
Neural stem cell migration toward gliomas in vitro
Neuro-oncol, October 1, 2005; 7(4): 476 - 484.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-K. Kim, T. G. Cargioli, M. Machluf, W. Yang, Y. Sun, R. Al-Hashem, S. U. Kim, P. M. Black, and R. S. Carroll
PEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model
Clin. Cancer Res., August 15, 2005; 11(16): 5965 - 5970.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Nakamizo, F. Marini, T. Amano, A. Khan, M. Studeny, J. Gumin, J. Chen, S. Hentschel, G. Vecil, J. Dembinski, et al.
Human Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Cancer Res., April 15, 2005; 65(8): 3307 - 3318.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco, and A. Vescovi
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Cancer Res., October 1, 2004; 64(19): 7011 - 7021.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Staflin, G. Honeth, S. Kalliomaki, C. Kjellman, K. Edvardsen, and M. Lindvall
Neural Progenitor Cell Lines Inhibit Rat Tumor Growth in Vivo
Cancer Res., August 1, 2004; 64(15): 5347 - 5354.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Ehtesham, P. Kabos, M. A. R. Gutierrez, N. H. C. Chung, T. S. Griffith, K. L. Black, and J. S. Yu
Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-related Apoptosis-inducing Ligand
Cancer Res., December 15, 2002; 62(24): 7170 - 7174.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.